Home

 

Participating Organizations
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (http://www.nichd.nih.gov/)

 

Components of Participating Organizations
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (http://www.nichd.nih.gov/)

 

Translational Research in Pediatric and Obstetric Pharmacology (R01)

New

 

PAR-09-155

 

NOTICE: Applications submitted in response to this Funding Opportunity Announcement (FOA) for Federal assistance must be submitted electronically through Grants.gov (http://www.grants.gov) using the SF424 Research and Related (R&R) forms and the SF424 (R&R) Application Guide. 

 

APPLICATIONS MAY NOT BE SUBMITTED IN PAPER FORMAT.

 

This FOA must be read in conjunction with the application guidelines included with this announcement in Grants.gov/Apply for Grants (hereafter called Grants.gov/Apply).

 

A registration process is necessary before submission and applicants are highly encouraged to start the process at least four (4) weeks prior to the grant submission date.

 

A compatible version of Adobe Reader is required for download. For Assistance downloading this or any Grants.gov application package, please contact Grants.gov Customer Support at http://grants.gov/CustomerSupport.

Catalog of Federal Domestic Assistance Number(s)
93.865

 

Key Dates
Release/Posted Date: April 10, 2009
Opening Date:  August 16, 2009 (Earliest date an application may be submitted to Grants.gov)
Letters of Intent Receipt Date(s): August 17, 2009
NOTE: On-time submission requires that applications be successfully submitted to Grants.gov no later than 5:00 p.m. local time (of the applicant institution/organization).
Application Due Date(s): September 16, 2009, January 19, 2010, May 19, 2010, September 16, 2010, January 19, 2011, May 19, 2011
AIDS Application Due Date(s): Not applicable
Peer Review Date(s): January/February 2010; May/June 2010; September/October 2010; January/February 2011; May/June 2011; September/October 2011
Council Review Date(s): May 2010, October 2010, January 2011, May 2011, October 2011, January 2012
Earliest Anticipated Start Date(s): July 2010, December 2010, April 2011, July 2011, December 2011, April 2012 
Additional Information to Be Available Date (Activation Date): Not Applicable
Expiration Date: May 20, 2011

Due Dates for E.O. 12372:  Not Applicable

 

• Purpose. This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development encourages research grant applications to conduct studies to improve existing drug saftey and efficacy, and to develop new drugs for pediatric and obstetric populations.  The overall goals of this FOA are to support: (1) pharmacological studies addressing the special differences of drug actions and responses among children at various developmental stages, between children and adults, and between pregnant and non-pregnant women; (2) development of new drug targeting children and pregnant women; (3) multidisciplinary collaborations between basic and physician scientists to improve the use of therapeutics in obstetrics and pediatrics.
  Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) mechanism and runs in parallel with FOAs of identical scientific scope, PAR-09-154 that encourages applications under the R03 grant mechanism and PAR-09-156 that encourages applications under the R21 grant mechanism.
• Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
• Budget and Project Period.  Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
• Application Research Plan Component Length: The R01 application Research Plan component of the PHS398 (Items 2-5) may not exceed 25 pages, including tables, graphs, figures, diagrams, and charts. See http://grants1.nih.gov/grants/funding/funding_program.htm
• Eligible Institutions/Organizations. Institutions/organizations listed in Section III, 1.A. are eligible to apply.
• Eligible Project Directors/Principal Investigators (PDs/PIs). Include Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
  Number of PDs/PIs. More than one PD/PI (i.e., multiple PDs/PIs), may be designated on the application.
• Number of Applications. Applicants may submit more than one application, provided that each application is scientifically distinct.
• Resubmissions. Applicants may submit a resubmission application, but such application must include an Introduction addressing the previous peer review critique (Summary Statement). See new NIH policy on resubmission (amended) applications (NOT-OD-09-003, NOT-OD-09-016).
• Renewals. Applicants may submit a renewal application.
• Special Date(s). This FOA uses non-standard due dates. See Receipt, Review and Anticipated Start Dates.
• Application Materials. See Section IV.1 for application materials.
• General Information. For general information on SF424 (R&R) Application and Electronic Submission, see these Web sites:
• SF424 (R&R) Application and Electronic Submission Information: http://grants.nih.gov/grants/funding/424/index.htm
• General information on Electronic Submission of Grant Applications: http://era.nih.gov/ElectronicReceipt/
• Hearing Impaired. Telecommunications for the hearing impaired are available at: TTY:  (301) 451-5936.